Q2 2026 revenue up 9% YoY, margins expanding, cash flow strong. Learn how deleveraging and mix shift could be rerated.

Alcon is officially ending its PowerVision IOL technology program after disappointing clinical study data. As a result, the Geneva, Switzerland-based company is taking a $402 million write-off related ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...

Alcon has reported Q2 revenues of around $2.8bn, indicative of an 8% uptick year-over-year (YoY), prompting it to revise its 2026 outlook. The Swiss eyecare specialist now expects 2026 earnings growth ...

Aug 11 (Reuters) - Swiss-American eye care company Alcon (ALCC.S), opens new tab ‌hiked its 2026 profitability target on Monday, helped by U.S. tariff refunds, which sent its shares around 4% higher ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Alcon is expanding toric parameter options for ...

Alcon and RxSight have announced a $200 million collaboration to develop post-operative adjustable presbyopic correction intraocular lenses (PCIOLs), marking a strategic pivot for Alcon after years of ...

Alcon’s DAILIES TOTAL1 daily disposable contact lenses target dry-eye discomfort with a water gradient design and high oxygen transmission, aiming to offer all-day comfort for U.S. wearers who prefer ...

Alcon Inc. has reported fresh quarterly numbers and updated its outlook, putting the eye care specialist on the radar of global and US-focused investors. What is behind the latest figures – and how ...

The comprehensive "Europe Pre-loaded Intraocular Lens (IOLs) Market, Global Outlook and Forecast 2022-2028 market" research report is essential for understanding current trends, consumer preferences, ...